Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 5;12(2):414.
doi: 10.3390/nu12020414.

The Efficacy of Squalene in Cardiovascular Disease Risk-A Systematic Review

Nurul 'Izzah Ibrahim  1 , Syed Fairus  2 , Mohamed S Zulfarina  1 , Isa Naina Mohamed  1
Affiliations

The Efficacy of Squalene in Cardiovascular Disease Risk-A Systematic Review

Nurul 'Izzah Ibrahim et al. Nutrients. .

Abstract

Introduction: Cardiovascular disease (CVD) is the leading cause of death worldwide. Squalene (SQ), an intermediate for the cholesterol biosynthesis, has been proposed to act similarly to statins via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase in the liver.

Purpose: This paper explores the effects of SQ in CVD.

Methods: A systematic review of the literature was performed to identify relevant studies about SQ and CVD. A comprehensive search in Medline and Scopus for relevant studies published between the years 1946 and 2019 was performed. The main inclusion criteria were that the study was published in English; that the study reported association or effect of SQ and CVD; and that CVD should be related to lifestyle variables, aging, or experimentally induced conditions.

Results: The literature searches identified 5562 potentially relevant articles, whereby 21 studies met the inclusion criteria. There were three human studies and 18 animal experimental studies included in this paper. Only one human study reported positive outcome of SQ in CVD. The remaining two studies reported inconsistent and/or no effect. For animal studies, 15 studies reported positive effect while the remaining reported negative and/or no effect of SQ on various related parameters.

Conclusions: This evidence-based review emphasizes the potential of SQ being used for cardiovascular-related diseases. The effect of SQ, especially of plant-based warrants further exploration. Controlled human observational studies should be performed to provide comprehensive evidence.

Keywords: atherosclerosis; cardiovascular disease; cholesterol; hyperlipidemic; squalene.

PubMed Disclaimer

Conflict of interest statement

The authors confirm that this article has no conflicts of interest.

Figures

Figure 1
Figure 1
Potential beneficial effects of squalene and the underlying mechanisms responsible for the effects [32,33]; 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA).
Figure 2
Figure 2
Chemical structure of Squalene (SQ).
Figure 3
Figure 3
Flow chart to show the selection process of the articles in this review.
See this image and copyright information in PMC

References

    1. World Health Organization Cardiovascular Disease. [(accessed on 17 June 2019)]; Available online: https://www.who.int/cardiovascular_diseases/en/
    1. Mendis S.P.P., Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. WHO; Geneva, Switzerland: 2011. [(accessed on 17 June 2019)]. Available online: https://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/
    1. Torpy J.M., Lynm C., Glass R.M. Risk Factors for Heart Disease. JAMA. 2003;290:980. doi: 10.1001/jama.290.7.980. - DOI - PubMed
    1. Havranek E.P., Mujahid M.S., Barr D.A., Blair I.V., Cohen M.S., Cruz-Flores S., Davey-Smith G., Dennison-Himmelfarb C.R., Lauer M.S., Lockwood D.W., et al. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2015;132:873–898. doi: 10.1161/CIR.0000000000000228. - DOI - PubMed
    1. Wilson P.W., D’Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. doi: 10.1161/01.CIR.97.18.1837. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources